Status:
COMPLETED
Assessment of the Impact of Acquisition Time, Respiratory Gating and New Qclear Reconstruction Modalities on the Quantification of Dosimetry in Selective Internal Radiotherapy
Lead Sponsor:
University Hospital, Bordeaux
Collaborating Sponsors:
GE Healthcare
Conditions:
Carcinoma, Hepatocellular
Eligibility:
All Genders
18+ years
Brief Summary
Post-processing of Positron Emission Tomography (PET) acquired images, performed following radioembolization treatment with microspheres at 90Y in hepatocellular carcinoma patients, is subject to chan...
Eligibility Criteria
Inclusion
- patient with hepatocellular carcinoma
- with radioembolization treatment decided
- over the age of 18
Exclusion
- radiembolization not possible
- acquisition of PET/CT imaging at 90Y not possible
Key Trial Info
Start Date :
April 12 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 10 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04903340
Start Date
April 12 2021
End Date
December 10 2021
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Bordeaux
Bordeaux, France, 33076